Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2022 Nov 10;13:1073445. doi: 10.3389/fphar.2022.1073445

Corrigendum: Adenosine receptor stimulation by polydeoxyribonucleotide improves tissue repair and symptomology in experimental colitis

Giovanni Pallio 1, Alessandra Bitto 1,*, Gabriele Pizzino 1, Federica Galfo 1, Natasha Irrera 1, Francesco Squadrito 1, Giovanni Squadrito 2, Socrate Pallio 1, Giuseppe P Anastasi 3, Giuseppina Cutroneo 2, Antonio Macrì 2, Domenica Altavilla 3
PMCID: PMC9685554  PMID: 36438841

In the published article, the Conflict of Interest statement was incorrectly filed. The correct Conflict of Interest statement appears below.

“Author FS has received research support from Mastelli for work on polydeoxyribonucleotide. Authors FS, AB and DA are co-inventors on a patent describing therapeutic polydeoxyribonucleotide activity in chronic intestinal disease.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES